- Filed
- Jan 26, 2022 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2021 · Dec 31, 2021 | 7.71M sh |
| Shares Diluted | FY 2021 · Oct 31, 2021 | 7.75M sh |
| Shares Diluted | FY 2021 · Oct 31, 2020 | 7.71M sh |
| Capex | FY 2021 · Oct 31, 2021 | $54.64K |
| Capex | FY 2021 · Oct 31, 2020 | $7.02K |
| Cash And Equivalents | FY 2021 · Oct 31, 2021 | $1.57M |
| Cash And Equivalents | FY 2021 · Oct 31, 2020 | $2.75M |
| Cash And Equivalents | FY 2021 · Oct 31, 2019 | $145.15K |
| Stockholders Equity | FY 2021 · Oct 31, 2021 | −$11.04M |
| Stockholders Equity | FY 2021 · Oct 31, 2020 | −$11.36M |
| Stockholders Equity | FY 2021 · Oct 31, 2019 | $455.73K |
| Current Liabilities | FY 2021 · Oct 31, 2021 | $3.68M |
| Current Liabilities | FY 2021 · Oct 31, 2020 | $5.48M |
| Total Liabilities | FY 2021 · Oct 31, 2021 | $14.88M |
| Total Liabilities | FY 2021 · Oct 31, 2020 | $16.7M |
| Current Assets | FY 2021 · Oct 31, 2021 | $2.63M |
| Current Assets | FY 2021 · Oct 31, 2020 | $3.57M |
| Total Assets | FY 2021 · Oct 31, 2021 | $3.84M |
| Total Assets | FY 2021 · Oct 31, 2020 | $5.34M |
| Eps Diluted | FY 2021 · Oct 31, 2021 | $0.01 |
| Eps Diluted | FY 2021 · Oct 31, 2020 | −$1.60 |
| Eps Basic | FY 2021 · Oct 31, 2021 | $0.01 |
| Eps Basic | FY 2021 · Oct 31, 2020 | −$1.60 |
| Sga Expense | FY 2021 · Oct 31, 2021 | $2.52M |
| Sga Expense | FY 2021 · Oct 31, 2020 | $6.47M |
| Rd Expense | FY 2021 · Oct 31, 2021 | $206.88K |
| Rd Expense | FY 2021 · Oct 31, 2020 | $338K |
| Net Income | FY 2021 · Oct 31, 2021 | $93.2K |
| Net Income | FY 2021 · Oct 31, 2020 | −$12.3M |
| Operating Income | FY 2021 · Oct 31, 2021 | $1.15M |
| Operating Income | FY 2021 · Oct 31, 2020 | −$11.34M |
| Cost Of Revenue | FY 2021 · Oct 31, 2021 | $2.28M |
| Cost Of Revenue | FY 2021 · Oct 31, 2020 | $6.19M |
| Revenue | FY 2021 · Oct 31, 2021 | $6.16M |
| Revenue | FY 2021 · Oct 31, 2020 | $11.53M |